CANC news

Tema Oncology · Biotechnology · United States · Genomics & Biotech Innovation

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
11.7% of CANC
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
14.2% of CANC
Seeking Alpha · 28 Oct 2026, 15:55 UTC
Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE) | Seeking Alpha
8.4% of CANC
Benzinga · 28 Oct 2026, 19:32 UTC
Traders Are Pricing a 7% Swing in Amazon Ahead of Earnings - Amazon.com (NASDAQ:AMZN), Intel (NASDAQ:INTC
6.9% of CANC
Where to buy CANC
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
24/7 Wall St. · 28 Oct 2026, 12:14 UTC
3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and Gilead
8.4% of CANC
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
6.9% of CANC
Where to buy CANC
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Yahoo! Finance · 27 Oct 2026, 15:16 UTC
4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
11.4% of CANC
Yahoo! Finance · 27 Oct 2026, 13:47 UTC
What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
11.7% of CANC
24/7 Wall St. · 28 Oct 2026, 19:24 UTC
16% of Employers Are Thinking About Cutting Weight-Loss Drug Coverage
4.8% of CANC
Seeking Alpha · 28 Oct 2026, 18:55 UTC
Roche: Valuation Leaves Limited Upside (OTCMKTS:RHHBF) | Seeking Alpha
4.2% of CANC
Benzinga · 28 Oct 2026, 13:25 UTC
Eli Lilly Says Retatrutide Delivers More Than Double Ozempic's Weight Loss in Late-Stage Diabetes Trial -
4.8% of CANC
The Manila times · 27 Oct 2026, 20:21 UTC
Revolution Medicines to Participate in November 2026 Investor Conferences
7.7% of CANC
Market Screener · 28 Oct 2026, 12:07 UTC
Eli Lilly And Company Announces Positive Topline Results From TRANSCEND-T2D-2 Phase 3 Trial Of Retatrutide In Adults With Type 2 Diabetes
4.8% of CANC
Benzinga · 28 Oct 2026, 10:04 UTC
Top Wall Street Forecasters Revamp Eli Lilly Expectations Ahead Of Q3 Earnings - Eli Lilly (NYSE:LLY)
4.8% of CANC
TheStreet · 28 Oct 2026, 19:33 UTC
Breakthrough cancer vaccine catches Wall Street's attention
3.6% of CANC
wallstreet:online · 28 Oct 2026, 14:05 UTC
Sandoz reports strong biosimilar-sales momentum; narrowed full-year net-sales range and upgrade to margin guidance
4.0% of CANC
Seeking Alpha · 28 Oct 2026, 12:00 UTC
Sandoz Group AG (SDZNY) Q3 2026 Sales/Trading Call Transcript | Seeking Alpha
4.0% of CANC
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
3.6% of CANC
The Manila times · 28 Oct 2026, 11:10 UTC
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
4.0% of CANC
The Wall Street Journal · 28 Oct 2026, 09:49 UTC
Sandoz Shares Fall After Company Turns Cautious on Sales Guidance
4.0% of CANC

CANC news

Where to buy CANC

Where to buy CANC